1	Epidemiology	Epidemiology	B-NP	NN	O	0	ROOT
2	,	,	O	,	O	7	P
3	clinical	clinical	B-NP	JJ	O	4	NMOD
4	manifestations	manifestation	I-NP	NNS	O	7	NMOD
5	,	,	O	,	O	7	P
6	and	and	O	CC	O	7	NMOD
7	outcomes	outcome	B-NP	NNS	O	1	OBJ
8	of	of	B-PP	IN	O	7	NMOD
9	Streptococcus	Streptococcus	B-NP	NNP	O	11	NMOD
10	suis	suis	I-NP	NN	O	11	NMOD
11	infection	infection	I-NP	NN	O	8	PMOD
12	in	in	B-PP	IN	O	7	NMOD
13	humans	human	B-NP	NNS	O	12	PMOD
14	.	.	O	.	O	1	P

1	Streptococcus	Streptococcus	B-NP	NNP	O	2	NMOD
2	suis	suis	I-NP	NNP	O	5	NMOD
3	,	,	O	,	O	5	P
4	a	a	B-NP	DT	O	5	NMOD
5	bacterium	bacterium	I-NP	NN	O	10	SUB
6	that	that	B-NP	WDT	O	5	NMOD
7	affects	affect	B-VP	VBZ	O	6	SBAR
8	pigs	pig	B-NP	NNS	O	7	OBJ
9	,	,	O	,	O	5	P
10	is	be	B-VP	VBZ	O	0	ROOT
11	a	a	B-NP	DT	O	13	NMOD
12	neglected	neglect	I-NP	VBN	O	13	NMOD
13	pathogen	pathogen	I-NP	NN	O	10	PRD
14	that	that	B-NP	WDT	O	13	NMOD
15	causes	cause	B-VP	VBZ	O	14	SBAR
16	systemic	systemic	B-NP	JJ	O	17	NMOD
17	disease	disease	I-NP	NN	O	15	OBJ
18	in	in	B-PP	IN	O	15	VMOD
19	humans	human	B-NP	NNS	O	18	PMOD
20	.	.	O	.	O	10	P

1	We	We	B-NP	PRP	O	2	SUB
2	conducted	conduct	B-VP	VBD	O	0	ROOT
3	a	a	B-NP	DT	O	5	NMOD
4	systematic	systematic	I-NP	JJ	O	5	NMOD
5	review	review	I-NP	NN	O	7	NMOD
6	and	and	I-NP	CC	O	7	NMOD
7	meta-analysis	meta-analysis	I-NP	NN	O	20	NMOD
8	to	to	B-VP	TO	O	9	VMOD
9	summarize	summarize	I-VP	VB	O	7	NMOD
10	global	global	B-NP	JJ	O	11	NMOD
11	estimates	estimate	I-NP	NNS	O	9	OBJ
12	of	of	B-PP	IN	O	11	NMOD
13	the	the	B-NP	DT	O	14	NMOD
14	epidemiology	epidemiology	I-NP	NN	O	12	PMOD
15	,	,	O	,	O	20	P
16	clinical	clinical	B-NP	JJ	O	17	NMOD
17	characteristics	characteristic	I-NP	NNS	O	20	NMOD
18	,	,	O	,	O	20	P
19	and	and	O	CC	O	20	NMOD
20	outcomes	outcome	B-NP	NNS	O	2	OBJ
21	of	of	B-PP	IN	O	20	NMOD
22	this	this	B-NP	DT	O	23	NMOD
23	zoonosis	zoonosis	I-NP	NN	O	21	PMOD
24	.	.	O	.	O	2	P

1	We	We	B-NP	PRP	O	2	SUB
2	searched	search	B-VP	VBD	O	0	ROOT
3	main	main	B-NP	JJ	O	5	NMOD
4	literature	literature	I-NP	NN	O	5	NMOD
5	databases	database	I-NP	NNS	O	2	OBJ
6	for	for	B-PP	IN	O	2	VMOD
7	all	all	B-NP	DT	O	8	NMOD
8	studies	study	I-NP	NNS	O	6	PMOD
9	through	through	B-PP	IN	O	2	VMOD
10	December	December	B-NP	NNP	O	9	PMOD
11	2012	2012	I-NP	CD	O	10	NMOD
12	using	use	B-VP	VBG	O	2	VMOD
13	the	the	B-NP	DT	O	18	NMOD
14	search	search	I-NP	NN	O	15	NMOD
15	term	term	I-NP	NN	O	18	NMOD
16	``	``	O	``	O	18	NMOD
17	streptococcus	streptococcus	B-NP	NN	O	18	NMOD
18	suis	suis	I-NP	NN	O	12	OBJ
19	.	.	O	.	O	2	P
20	''	''	O	''	O	2	VMOD

1	The	The	B-NP	DT	O	2	NMOD
2	prevalence	prevalence	I-NP	NN	O	7	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	S.	S.	B-NP	NNP	O	6	NMOD
5	suis	suis	I-NP	NN	O	6	NMOD
6	infection	infection	I-NP	NN	O	3	PMOD
7	is	be	B-VP	VBZ	O	16	VMOD
8	highest	high	B-ADJP	JJS	O	7	VMOD
9	in	in	B-PP	IN	O	8	AMOD
10	Asia	Asia	B-NP	NNP	O	9	PMOD
11	;	;	O	:	O	16	P
12	the	the	B-NP	DT	O	15	NMOD
13	primary	primary	I-NP	JJ	B-protein	15	NMOD
14	risk	risk	I-NP	NN	I-protein	15	NMOD
15	factors	factor	I-NP	NNS	I-protein	16	SUB
16	are	be	B-VP	VBP	O	0	ROOT
17	occupational	occupational	B-NP	JJ	O	18	NMOD
18	exposure	exposure	I-NP	NN	O	20	NMOD
19	and	and	I-NP	CC	O	20	NMOD
20	eating	eating	I-NP	NN	O	16	PRD
21	of	of	B-PP	IN	O	20	NMOD
22	contaminated	contaminate	B-NP	VBN	O	23	NMOD
23	food	food	I-NP	NN	O	21	PMOD
24	.	.	O	.	O	16	P

1	The	The	B-NP	DT	O	3	NMOD
2	pooled	pooled	I-NP	JJ	O	3	NMOD
3	proportions	proportion	I-NP	NNS	O	10	NMOD
4	of	of	B-PP	IN	O	3	NMOD
5	case-patients	case-patient	B-NP	NNS	O	4	PMOD
6	with	with	B-PP	IN	O	5	NMOD
7	pig-related	pig-related	B-NP	JJ	O	8	NMOD
8	occupations	occupation	I-NP	NNS	O	6	PMOD
9	and	and	O	CC	O	10	NMOD
10	history	history	B-NP	NN	O	15	SUB
11	of	of	B-PP	IN	O	10	NMOD
12	eating	eat	B-VP	VBG	O	11	PMOD
13	high-risk	high-risk	B-NP	JJ	O	14	NMOD
14	food	food	I-NP	NN	O	12	OBJ
15	were	be	B-VP	VBD	O	0	ROOT
16	38.1	38.1	B-NP	CD	O	17	NMOD
17	%	%	I-NP	NN	O	20	NMOD
18	and	and	O	CC	O	20	NMOD
19	37.3	37.3	B-NP	CD	O	20	NMOD
20	%	%	I-NP	NN	O	15	PRD
21	,	,	O	,	O	20	P
22	respectively	respectively	B-ADVP	RB	O	20	NMOD
23	.	.	O	.	O	15	P

1	The	The	B-NP	DT	O	4	NMOD
2	main	main	I-NP	JJ	O	4	NMOD
3	clinical	clinical	I-NP	JJ	O	4	NMOD
4	syndrome	syndrome	I-NP	NN	O	5	SUB
5	was	be	B-VP	VBD	O	0	ROOT
6	meningitis	meningitis	B-NP	NN	O	5	PRD
7	(	(	O	(	O	12	DEP
8	pooled	pool	B-VP	VBN	O	12	DEP
9	rate	rate	B-NP	NN	O	11	NMOD
10	68.0	68.0	B-NP	CD	O	11	NMOD
11	%	%	I-NP	NN	O	8	VMOD
12	)	)	O	)	O	6	NMOD
13	,	,	O	,	O	6	P
14	followed	follow	B-VP	VBN	O	6	NMOD
15	by	by	B-PP	IN	O	14	VMOD
16	sepsis	sepsis	B-NP	NN	O	23	NMOD
17	,	,	O	,	O	23	P
18	arthritis	arthritis	B-NP	NN	O	23	NMOD
19	,	,	O	,	O	23	P
20	endocarditis	endocarditis	B-NP	NN	O	23	NMOD
21	,	,	O	,	O	23	P
22	and	and	O	CC	O	23	NMOD
23	endophthalmitis	endophthalmitis	B-NP	NN	O	15	PMOD
24	.	.	O	.	O	5	P

1	The	The	B-NP	DT	O	4	NMOD
2	pooled	pooled	I-NP	JJ	O	4	NMOD
3	case-fatality	case-fatality	I-NP	NN	O	4	NMOD
4	rate	rate	I-NP	NN	O	5	SUB
5	was	be	B-VP	VBD	O	0	ROOT
6	12.8	12.8	B-NP	CD	O	7	NMOD
7	%	%	I-NP	NN	O	5	PRD
8	.	.	O	.	O	5	P

1	Sequelae	Sequelae	B-NP	NNP	O	2	SUB
2	included	include	B-VP	VBD	O	0	ROOT
3	hearing	hearing	B-NP	NN	O	4	NMOD
4	loss	loss	I-NP	NN	O	11	NMOD
5	(	(	O	(	O	8	DEP
6	39.1	39.1	B-NP	CD	O	7	NMOD
7	%	%	I-NP	NN	O	8	DEP
8	)	)	O	)	O	4	NMOD
9	and	and	O	CC	O	11	NMOD
10	vestibular	vestibular	B-NP	JJ	O	11	NMOD
11	dysfunction	dysfunction	I-NP	NN	O	2	OBJ
12	(	(	O	(	O	15	DEP
13	22.7	22.7	B-NP	CD	O	14	NMOD
14	%	%	I-NP	NN	O	15	DEP
15	)	)	O	)	O	11	NMOD
16	.	.	O	.	O	2	P

1	Our	Our	B-NP	PRP$	O	2	NMOD
2	analysis	analysis	I-NP	NN	O	3	SUB
3	identified	identify	B-VP	VBD	O	0	ROOT
4	gaps	gap	B-NP	NNS	O	3	OBJ
5	in	in	B-PP	IN	O	4	NMOD
6	the	the	B-NP	DT	O	7	NMOD
7	literature	literature	I-NP	NN	O	5	PMOD
8	,	,	O	,	O	4	P
9	particularly	particularly	B-ADVP	RB	O	10	PMOD
10	in	in	B-PP	IN	O	4	NMOD
11	assessing	assess	B-VP	VBG	O	10	PMOD
12	risk	risk	B-NP	NN	O	13	NMOD
13	factors	factor	I-NP	NNS	O	15	NMOD
14	and	and	O	CC	O	15	NMOD
15	sequelae	sequela	B-NP	NNS	O	11	OBJ
16	of	of	B-PP	IN	O	15	NMOD
17	this	this	B-NP	DT	O	18	NMOD
18	infection	infection	I-NP	NN	O	16	PMOD
19	.	.	O	.	O	3	P

